Molecular characterization of HER2-positive (HER2+) metastatic gastric and gastro-esophageal junction cancer patients (mGC): Identification of resistance mechanisms to trastuzumab-based therapy (TTZ)

  1. Alsina, M.
  2. Hierro, C.
  3. Sastre, J.
  4. Guardeño, R.
  5. Lopez, C.
  6. Pineda, E.
  7. Aranda, E.
  8. Manzano, J.L.
  9. Galán, M.
  10. Longo, F.
  11. Visa, L.
  12. Landolfi, S.
  13. Jimenez, J.
  14. Sperinde, J.
  15. Pandiella, A.
  16. Tabernero, J.
  17. Hernandez-Losa, J.
  18. Arribas, J.
  19. Scaltriti, M.
  20. Nuciforo, P.
Aldizkaria:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Argitalpen urtea: 2016

Alea: 27

Orrialdeak: vi213

Mota: Artikulua

DOI: 10.1093/ANNONC/MDW371.21 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus